{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:17:50Z","timestamp":1780568270842,"version":"3.54.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p>To develop a pharmacokinetic-pharmacogenomic population model of morphine in critically ill children with acute respiratory failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design:<\/jats:title><jats:p>Prospective pharmacokinetic-pharmacogenomic observational study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting:<\/jats:title><jats:p>Thirteen PICUs across the United States.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients:<\/jats:title><jats:p>Pediatric subjects (<jats:italic toggle=\"yes\">n<\/jats:italic>= 66) mechanically ventilated for acute respiratory failure, weight greater than or equal to 7\u2009kg, receiving morphine and\/or midazolam continuous infusions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions:<\/jats:title><jats:p>Serial blood sampling for drug quantification and a single blood collection for genomic evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and Main Results:<\/jats:title><jats:p>Concentrations of morphine, the two main metabolites, morphine-3-glucuronide and morphine-6-glucuronide, were quantified by high-performance liquid chromatography tandem mass spectrometry\/mass spectroscopy. Subjects were genotyped using the Illumina HumanOmniExpress genome-wide single nucleotide polymorphism chip. Nonlinear mixed-effects modeling was performed to develop the pharmacokinetic-pharmacogenomic model. A two-compartment model with linear elimination and two individual compartments for metabolites best describe morphine disposition in this population. Our analysis demonstrates that body weight and postmenstrual age are relevant predictors of pharmacokinetic parameters of morphine and its metabolites. Furthermore, our research shows that a duration of mechanical ventilation greater than or equal to 10 days reduces metabolite formation and elimination upwards of 30%. However, due to the small sample size and relative heterogeneity of the population, no heritable factors associated with uridine diphosphate glucuronyl transferase 2B7 metabolism of morphine were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>The results provide a better understanding of the disposition of morphine and its metabolites in critically ill children with acute respiratory failure requiring mechanical ventilation due to nonheritable factors. It also provides the groundwork for developing additional studies to investigate the role of heritable factors.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ccm.0000000000003741","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T12:51:12Z","timestamp":1553777472000},"page":"e485-e494","source":"Crossref","is-referenced-by-count":12,"title":["Morphine Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study"],"prefix":"10.1097","volume":"47","author":[{"given":"Athena F.","family":"Zuppa","sequence":"first","affiliation":[{"name":"Department of Pediatric Anesthesia and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Children\u2019s Hospital of Philadelphia, Center for Clinical Pharmacology, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle R.","family":"Benitez","sequence":"additional","affiliation":[{"name":"Long Island University Brooklyn Campus, Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R.","family":"Zane","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Center for Clinical Pharmacology, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A. Q.","family":"Curley","sequence":"additional","affiliation":[{"name":"Family and Community Heath, University of Pennsylvania School of Nursing, Philadelphia, PA."},{"name":"Anesthesia and Critical Care Medicine, Perelman School of Medicine, Philadelphia, PA."},{"name":"Research Institute, Children\u2019s Hospital of Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bradfield","sequence":"additional","affiliation":[{"name":"Quantinuum Research LLC, San Diego, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Center for Applied Genomics, Philadelphia, PA."},{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine S.","family":"Gastonguay","sequence":"additional","affiliation":[{"name":"Metrum Research Group, Tariffville, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Moorthy","sequence":"additional","affiliation":[{"name":"Department of Pediatric Anesthesia and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Children\u2019s Hospital of Philadelphia, Center for Clinical Pharmacology, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Prodell","sequence":"additional","affiliation":[{"name":"Department of Pediatric Anesthesia and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Children\u2019s Hospital of Philadelphia, Center for Clinical Pharmacology, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Gastonguay","sequence":"additional","affiliation":[{"name":"Metrum Research Group, Tariffville, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230815","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMra1208705","article-title":"Sedation and delirium in the intensive care unit.","volume":"370","author":"Reade","year":"2014","journal-title":"N Engl J Med"},{"key":"R2-20230815","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/0091270005280966","article-title":"Drug utilization in the pediatric intensive care unit: Monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children.","volume":"45","author":"Zuppa","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R3-20230815","doi-asserted-by":"crossref","first-page":"527, viii","DOI":"10.1016\/j.ccc.2009.05.004","article-title":"Altering intensive care sedation paradigms to improve patient outcomes.","volume":"25","author":"Riker","year":"2009","journal-title":"Crit Care Clin"},{"key":"R4-20230815","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc12679","article-title":"Intensive care sedation: The past, present and the future.","volume":"17","author":"Shehabi","year":"2013","journal-title":"Crit Care"},{"key":"R5-20230815","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1034\/j.1399-6576.2001.045007795.x","article-title":"Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review.","volume":"45","author":"Walder","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"R6-20230815","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00000542-200504000-00019","article-title":"Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery.","volume":"102","author":"Sinatra","year":"2005","journal-title":"Anesthesiology"},{"key":"R7-20230815","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children.","volume":"125","author":"Anand","year":"2010","journal-title":"Pediatrics"},{"key":"R8-20230815","doi-asserted-by":"crossref","first-page":"735, xii","DOI":"10.1016\/j.pcl.2008.02.017","article-title":"Pharmacokinetics and pharmacodynamics in the critically ill child.","volume":"55","author":"Zuppa","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"R9-20230815","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2014.05.007","article-title":"The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.","volume":"77","author":"Hites","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"R10-20230815","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(04)16815-3","article-title":"Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation.","volume":"364","author":"Singer","year":"2004","journal-title":"Lancet"},{"key":"R11-20230815","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11095-016-2033-y","article-title":"Clinical pharmacology studies in critically ill children.","volume":"34","author":"Thakkar","year":"2017","journal-title":"Pharm Res"},{"key":"R12-20230815","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/PCC.0b013e31819a3bb9","article-title":"Efficacy of sedation regimens to facilitate mechanical ventilation in the pediatric intensive care unit: A systematic review.","volume":"10","author":"Hartman","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20230815","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.tpj.6500139","article-title":"Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: Identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.","volume":"3","author":"Holthe","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"R14-20230815","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bcpt.12248","article-title":"Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption.","volume":"115","author":"Bastami","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R15-20230815","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-009-1029-2","article-title":"Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.","volume":"65","author":"Fujita","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"R16-20230815","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1213\/ANE.0000000000000936","article-title":"Morphine glucuronidation and elimination in intensive care patients: A comparison with healthy volunteers.","volume":"121","author":"Ahlers","year":"2015","journal-title":"Anesth Analg"},{"key":"R17-20230815","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00134-004-2545-5","article-title":"Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.","volume":"31","author":"Peters","year":"2005","journal-title":"Intensive Care Med"},{"key":"R18-20230815","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: A randomized clinical trial.","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA"},{"key":"R19-20230815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2017.09.030","article-title":"Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.","volume":"1067","author":"Moorthy","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R20-20230815","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/bmc.1394","article-title":"Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.","volume":"24","author":"Ahsman","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"R21-20230815","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmpb.2012.08.009","article-title":"Facilitating pharmacometric workflow with the metrumrg package for R.","volume":"109","author":"Bergsma","year":"2013","journal-title":"Comput Methods Programs Biomed"},{"key":"R22-20230815","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","article-title":"Likelihood based approaches to handling data below the quantification limit using NONMEM VI.","volume":"35","author":"Ahn","year":"2008","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R23-20230815","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit.","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R24-20230815","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00431-006-0189-x","article-title":"Population clinical pharmacology of children: Modelling covariate effects.","volume":"165","author":"Anderson","year":"2006","journal-title":"Eur J Pediatr"},{"key":"R25-20230815","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.","volume":"60","author":"L\u00f6tsch","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R26-20230815","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/dmd.107.019281","article-title":"Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.","volume":"36","author":"Ohno","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"R27-20230815","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2165\/00003088-199324040-00007","article-title":"Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.","volume":"24","author":"Hasselstr\u00f6m","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R28-20230815","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejps.2016.06.026","article-title":"Pharmacokinetic models of morphine and its metabolites in neonates: Systematic comparisons of models from the literature, and development of a new meta-model.","volume":"92","author":"Kn\u00f8sgaard","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"R29-20230815","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aeh042","article-title":"Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.","volume":"92","author":"Bouwmeester","year":"2004","journal-title":"Br J Anaesth"},{"key":"R30-20230815","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide.","volume":"90","author":"Penson","year":"2001","journal-title":"J Pharm Sci"},{"key":"R31-20230815","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents.","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-20230815","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FPC.0b013e32835ce485","article-title":"Variability in UDP-glucuronosyltransferase genes and morphine metabolism: Observations from a cross-sectional multicenter study in advanced cancer patients with pain.","volume":"23","author":"Fladvad","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R33-20230815","doi-asserted-by":"crossref","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","article-title":"A flexible and accurate genotype imputation method for the next generation of genome-wide association studies.","volume":"5","author":"Howie","year":"2009","journal-title":"PLoS Genet"},{"key":"R34-20230815","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2125.1989.tb05399.x","article-title":"The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.","volume":"27","author":"Hoskin","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"R35-20230815","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200140070-00001","article-title":"Morphine-6-glucuronide: An analgesic of the future?","volume":"40","author":"L\u00f6tsch","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R36-20230815","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","article-title":"Human renal function maturation: A quantitative description using weight and postmenstrual age.","volume":"24","author":"Rhodin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R37-20230815","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2133\/dmpk.24.25","article-title":"Mechanistic basis of using body size and maturation to predict clearance in humans.","volume":"24","author":"Anderson","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"R38-20230815","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00003088-200948060-00003","article-title":"Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.","volume":"48","author":"Knibbe","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R39-20230815","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00228-002-0490-1","article-title":"Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.","volume":"58","author":"Holthe","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R40-20230815","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","article-title":"Clinical response to morphine in cancer patients and genetic variation in candidate genes.","volume":"5","author":"Ross","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R41-20230815","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2125.1989.tb03548.x","article-title":"Morphine metabolism in children.","volume":"28","author":"Choonara","year":"1989","journal-title":"Br J Clin Pharmacol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201906000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T07:27:07Z","timestamp":1721114827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201906000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003741","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}